Skip to main content
. 2022 Oct 25;27(21):7218. doi: 10.3390/molecules27217218

Figure 5.

Figure 5

The thrombolytic effect of spermine NONOate+ UTMD. (A) Femoral blood flow velocity in control animals, (B) 24 h after thrombus formation without treatment, (C) 24 h after thrombus formation and free spermine NONOate treatment, and (D) 24 h after thrombus formation and spermine-NONOate-loaded microbubble and US stimulus treatments. Each trace or picture represents one experiment with 5 animals.